Vanguard Fiduciary Trust
NVAX icon

Vanguard Fiduciary Trust’s Novavax NVAX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Sell
1,085,100
-22,086
-2% -$198K ﹤0.01% 1797
2026
Q1 		$9.01M Buy
+1,107,186
New +$10M ﹤0.01% 1774

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Vanguard Fiduciary Trust's NVAX Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Novavax (NVAX) stake by 2% in Q2 2026, selling an estimated $198K and leaving 1,085,100 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1797.

Vanguard Fiduciary Trust first reported a position in NVAX in Q1 2026 and has held it in 2 quarters since. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,085,100 shares of Novavax worth $10.2M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 22,086 Novavax shares in Q2 2026, an estimated $198K.
  • Novavax made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1797 holding.
  • Vanguard Fiduciary Trust first reported a position in Novavax in Q1 2026 and has held it in 2 quarters since.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.